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Sir,
Uncommon manifestations of chronic
graft versus host disease (GvHD) include
a variety of neurological presentations
(Bolger et al., 1986; Urbano-Marquez
et al., 1986; Nelson and McQuillen, 1988;
Tse et al., 1999; Takahashi et al., 2000;
Ma et al., 2002; Nagashima et al., 2002)
and sclerodermatous skin changes (Shul-
man et al., 1978; Chosidow et al., 1992;
Janin et al., 1994; Penas et al., 2002). Here
we report a case of chronic GvHD fasciitis
presenting with progressive muscular
cramps and weakness, not previously
reported.
The patient was diagnosed with Hodg-
kin’s disease in 1983 at the age of 19 years,
suﬀering two relapses in 1987 and 1997. In
1999, he developed a plasmacytoma and
severe auto-immune haemolytic anaemia
which were treated with chemotherapy
and cyclosporin, respectively, followed by
a reduced intensity allogeneic bone mar-
row transplant. Two months later, he
developed mild GvHD with skin and liver
involvement, treated with oral steroids.
Over the following year, he developed
chronic skin changes requiring intraven-
ous methylprednisolone followed by
maintenance prednisolone and cyclo
sporin A.
In 2001, he was referred to neurology
with a 1-year history of painful muscular
cramps particularly around his mouth and
neck, across his stomach and in his legs
and hands, as well as muscular stiﬀness
and proximal weakness. Examination
revealed mild wasting of the left interossei
and mild bilateral hip ﬂexion weakness.
Tone and power were otherwise normal.
Reﬂexes were absent apart from knee
jerks. Plantars were ﬂexor. There was mild
reduction of pain and temperature sensa-
tion in the hands. Creatine kinase was
normal.
By January 2002, his skin had become
thickened and sclerodermatous, requiring
PUVA therapy, which resulted in some
improvement. He had no other features of
GvHD and his steroid dose was reduced.
However, the severe muscle cramps con-
tinued, failing to respond to baclofen or
dantrolene. He also developed more
proximal limb weakness. A vastus medi-
alis muscle biopsy was performed.
The biopsy showed a moderate inﬂam-
matory cell inﬁltrate within a thickened
perimysium, consisting predominantly of
T lymphocytes and macrophages
(Fig. 1a). There was perifascicular atro-
phy with occasional necrotic ﬁbres at the
periphery of fascicles. Following immun-
ocytochemistry increased sarcolemmal
expression of class 1 major histocompat-
ibility antigen was noted in perifascicular
ﬁbres (Fig. 1b).
The cramps continued to progress in
association with worsening, primarily
proximal weakness, distal wasting and
joint pains and stiﬀness, resulting in
reduction in mobility and requiring
increasing doses of opiates for pain con-
trol. Treatment with steroids, mycophe-
nolate, intravenous immunoglobulin,
methotrexate, clofazimine or inﬂiximab
failed to halt his progression. Sympto-
matic trials of phenytoin and gabapentin
were unsuccessful.
Sclerodermatous chronic GvHD is a
rare but well recognized form of GvHD
(Van den Bergh et al., 1987; Chosidow
et al., 1992; Penas et al., 2002). Muscular
presentations are more rarely reported
Figure 1 (a) Muscle showing scattered lymphocytes and macrophages (arrow heads) within
a thickened perimysium and scattered atrophic ﬁbres at the edge of the fascicle. (b) Fol-
lowing immunocytochemistry with an antibody to ß2-microglobulin, increased sarco-
lemmmal expression of Class 1 MHC antigen is noted in perifascicular ﬁbres.
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and include myositis (Urbano-Marquez
et al., 1986; Nelson and McQuillen, 1988;
Takahashi et al., 2000), occasionally in
association with myasthenia gravis (Tse
et al., 1999). Muscle biopsy ﬁndings in
chronic GvHD fasciitis have been repor-
ted previously and are summarized in
Table 1. None of these patients developed
the severe muscular cramps and progres-
sive weakness and wasting which are the
main features of the present case. We
speculate that these symptoms are
secondary to chronic inﬂammation and
ﬁbrosis of the perimysium causing
muscular ischaemia. The present patient
responded poorly to immunosuppressant
therapy, in keeping with previously
reported cases (Janin et al., 1994),
although other authors report more
favourable treatment outcomes (Van den
Bergh et al., 1987; Penas et al., 2002).
This case represents a previously
unreported neurological presentation of
chronic GvHD and a rare cause of
muscle cramps.
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A 79-year old lady was pre-treated with
cathartics before undergoing elective
colonoscopy. Soon she developed severe
hyponatraemia, with seizures and coma.
After rapid correction of sodium levels she
regained consciousness but presented an
impressive ataxic syndrome due to a by
means of MRI veriﬁed Central Pontine
Myelinolysis. We discuss the clinical and
imaging features, as well as the possible
pathogenetic mechanism of this rare
neurological disease.
Central pontine myelinolysis (CPM) is
a rare neurological disease of unknown
aetiopathogenesis, characterized by de-
myelinating lesions localized mostly in the
pons (Adams et al., 1959; Sterns et al.,
1986). Some investigators have attributed
it to rapidly corrected severe hyponatrae-
mia (Sterns et al., 1986; Laureno and
Karp, 1997), whereas others strongly
doubt this theory (Ayus et al., 1985;
Arieff, 1986).
We report the case of a 79-year-old lady
with a history of hypertension treated with
thiazides, normal sodium levels and no
changes suggestive of extracellular ﬂuid
volume losses, who underwent elective
colonoscopy after pre-treatment with
cathartics. Six hours after the examination
an increasing state of confusion followed
by an epileptic seizure was observed. The
patient remained thereafter comatose. At
this time severe hyponatraemia
(108 mmol/l) was detected. Brain-CT was
normal. Although there were no signs of
cerebral oedema anti-oedematous treat-
ment with intravenous dexamethason was
initiated. Almost 12 h later and after rapid
correction of hyponatraemia (>2 mmol/l/
h) up to 132 mmol/l she regained con-
sciousness but was unable to speak and
swallow. This condition remained stable
for 3 days, when external neurological
evaluation was asked. On examination the
patient was fully alert and orientated.
However, she presented severe dysarthria
and dysphagia. Due to a severe truncal
ataxia she was unable to sit without
support. There were no motor or sensory
deﬁcits. This combined cerebellar-pontine
syndrome on the background of the elec-
trolytic derangement suggested CPM.
MRI was then performed. T2-weighted
and Flair images demonstrated a large
hyperintense central lesion without peri-
focal oedema respecting the surface of the
pons. On T1-weighted images the lesion
was hypointense without contrast
enhancement (Fig. 1). Diﬀusion-weighted
images showed high signal intensity in the
borderzone between lesion and intact tis-
sue, whereas MR spectroscopy disclosed a
slight NAA reduction without lactate
increase (Fig. 2). These imaging ﬁndings
are typical for demyelination of osmotic
aetiology and conﬁrmed the clinical diag-
nosis of CPM (Laubenberger et al., 1996;
Ruzek et al., 2004). Within 2 weeks the
patient could eat, drink and walk with
assistance. At follow-up 3 months later she
Figure 2 (a) Diffusion-weighted MR images demonstrate reduced tissue diffusion with
high-intensity signal in the periphery of the lesion in the borderzone between intact and
affected pontine tissue. (b) MR spectroscopy reveals a slight NAA reduction with slightly
elevated lipid concentration as sign of cellular membrane lesion and excludes an ischaemic
pathology by failing to detect lactate.
Figure 1 MRI scans showing in all three directions a large demyelinating lesion of the
basis pontis (2·1.5·2.7 cm), respecting the pontine surface and partially affecting the
cerebellar peduncles, with no contrast enhancement or perifocal oedema.
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